Submitted by Anonymous (not verified) on 12 July 2024 - 12:17
Human medicines European public assessment report (EPAR): Livmarli, Maralixibat chloride, Date of authorisation: 09/12/2022, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Livmarli, Maralixibat chloride, Date of authorisation: 09/12/2022, Revision: 7, Status: Authorised